US 9393271
GHRH agonists for islet cell transplantation and function and the treatment of diabetes
granted A61KA61K35/28A61K35/39
Quick answer
US patent 9393271 (GHRH agonists for islet cell transplantation and function and the treatment of diabetes) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- Grant date
- Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K35/28, A61K35/39, A61K38/25